A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis.
Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
The primary objective is to compare the efficacy between three doses of AZD0865 (25, 50 and
75 mg).
The secondary objectives are to compare the efficacy between the three doses of AZD0865 and
esomeprazole 40 mg and to evaluate the safety and tolerability of AZD0865.